alexa Guifang Guo
ISSN: 2167-7700

Chemotherapy: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Guifang Guo

State Key Laboratory of Oncology in South China
Sun Yat-sen University Cancer Center, Guangzhou, P.R. China

Guo Guifang specializes in the medical treatment of such common tumors as intestinal cancer and lung cancer. She has delved into the treatment of intestinal cancer and presided over related state projects. She is adept at comprehensive treatment of common tumors. She has been engaged in diagnosis and treatment of VIP tumor patients for over ten years. She has extended  her valuable service as an associate chief physician in Sun Yat-sen University Cancer Center, China for 15 years and has been a recipient of many award and grants.

Research Interest

 Malignant tumours

Cancer Research


Tumors of CNS

Neuro endocrine tumors


A Potential Administration-time Dependent Effect of Bevacizumab in Improving Overall Survival and Increasing Metastasis in Metastatic Colorectal Cancer

Bei Zhang, Wenzhuo He, Feifei Zhou, Guifang Guo, Chang Jiang, Chenxi Yin, Xuxian Chen, Huijuan Qiu, Yuming Rong and Liangping Xia

Research Article: Chemotherapy 2013, 2: 108

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version